Health tech leaders look to design to make care more equitable – STAT

Health tech leaders look to design to make care more equitable – STAT

At the opening of each of her clinics, there’s a moment when Carolyn Witte, the founder and chief executive officer of women’s health startup Tia, holds her breath. “We call it the ‘shoulder-drop moment,’” Witte told STAT. During those few seconds, as a patient is opening the doors to one of Tia’s offices, Witte watches for them to turn from apprehension — about the idea of a rushed meeting with a new doctor or the notion of changing into a papery gown in a cold, industrially-lit room — to comfort. Witte hopes that during that moment, when patients see the colorful, sunlit environment, they feel welcomed instead of alienated.

Witte’s efforts to create clinics welcoming to women — along with a digital platform that includes a dedicated care team and encourages face time with providers — are part of a growing movement towards inclusivity in health tech.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.
Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.